I started my PhD in 2011, working on the host-Respiratory syncytial virus interaction. After finishing my PhD in 2018, I started a Postdoc working on studying the role of N-glycosylation on the immunogenicity of the influenza haemagglutinin and neuraminidase antigens. Since the start of the Covid19 pandemic, I am responsible for starting-up and supervising a biosafety level-3 laboratory to study the SARS-CoV-2 virus as well as other biosafety level-3 pathogens.